Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Functions and therapeutic applications of pseudouridylation

Abstract

The success of using pseudouridine (Ψ) and its methylation derivative in mRNA vaccines against SARS-CoV-2 has sparked a renewed interest in this RNA modification, known as the ‘fifth nucleotide’ of RNA. In this Review, we discuss the emerging functions of pseudouridylation in gene regulation, focusing on how pseudouridine in mRNA, tRNA and ribosomal RNA (rRNA) regulates translation. We also discuss the effects of pseudouridylation on RNA secondary structure, pre-mRNA splicing, and in vitro mRNA stability. In addition to nuclear-genome-encoded RNAs, pseudouridine is also present in mitochondria-encoded rRNA, mRNA and tRNA, where it has different distributions and functions compared with their nuclear counterparts. We then discuss the therapeutic potential of programmable pseudouridylation and mRNA vaccine optimization through pseudouridylation. Lastly, we briefly describe the latest quantitative pseudouridine detection methods. We posit that pseudouridine is a highly promising modification that merits further epitranscriptomics investigation and therapeutic application.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Roles of pseudouridylation in translation regulation.
Fig. 2: Roles of pseudouridylation in RNA structure and pre-mRNA splicing.
Fig. 3: The landscape of pseudouridine in nuclear-genome-encoded RNA and mitochondria-encoded RNA.
Fig. 4: Programmable pseudouridylation for suppression of nonsense mutations.
Fig. 5: Pseudouridylation in mRNA vaccines suppresses mRNA sensing by innate immune factors.

Similar content being viewed by others

References

  1. Kierzek, E. et al. The contribution of pseudouridine to stabilities and structure of RNAs. Nucleic Acids Res. 42, 3492–3501 (2014).

    Article  PubMed  CAS  Google Scholar 

  2. Li, X. Y., Ma, S. Q. & Yi, C. Q. Pseudouridine: the fifth RNA nucleotide with renewed interests. Curr. Opin. Chem. Biol. 33, 108–116 (2016).

    Article  PubMed  CAS  Google Scholar 

  3. Marchand, V. et al. HydraPsiSeq: a method for systematic and quantitative mapping of pseudouridines in RNA. Nucleic Acids Res. 48, e110 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Roundtree, I. A., Evans, M. E., Pan, T. & He, C. Dynamic RNA modifications in gene expression regulation. Cell 169, 1187–1200 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Li, X. et al. Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome. Nat. Chem. Biol. 11, 592–597 (2015).

    Article  PubMed  CAS  Google Scholar 

  6. Schwartz, S. et al. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell 159, 148–162 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Carlile, T. M. et al. Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells. Nature 515, 143-+ (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Yoon, A. et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312, 902–906 (2006).

    Article  PubMed  CAS  Google Scholar 

  9. Penzo, M. et al. Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation. FASEB J. 29, 3472–3482 (2015).

    Article  PubMed  CAS  Google Scholar 

  10. Barozzi, C. et al. Alterations of ribosomal RNA pseudouridylation in human breast cancer. Nar. Cancer 5, zcad026 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Keszthelyi, T. M. & Tory, K. The importance of pseudouridylation: human disorders related to the fifth nucleoside. Biol. Futur. 74, 3–15 (2023).

    Article  PubMed  Google Scholar 

  12. Bykhovskaya, Y., Casas, K., Mengesha, E., Inbal, A. & Fischel-Ghodsian, N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am. J. Hum. Genet. 74, 1303–1308 (2004).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Shaheen, R. et al. A homozygous truncating mutation in PUS3 expands the role of tRNA modification in normal cognition. Hum. Genet. 135, 707–713 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Shaheen, R. et al. PUS7 mutations impair pseudouridylation in humans and cause intellectual disability and microcephaly. Hum. Genet. 138, 231–239 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Frye, M., Jaffrey, S. R., Pan, T., Rechavi, G. & Suzuki, T. RNA modifications: what have we learned and where are we headed? Nat. Rev. Genet. 17, 365–372 (2016).

    Article  PubMed  CAS  Google Scholar 

  16. Delaunay, S. & Frye, M. RNA modifications regulating cell fate in cancer. Nat. Cell Biol. 21, 552–559 (2019).

    Article  PubMed  CAS  Google Scholar 

  17. Wang, M. K., Gao, C. C. & Yang, Y. G. Emerging roles of RNA methylation in development. Acc. Chem. Res. 56, 3417–3427 (2023).

    Article  PubMed  CAS  Google Scholar 

  18. Wiener, D. & Schwartz, S. The epitranscriptome beyond m6A. Nat. Rev. Genet. 22, 119–131 (2021).

    Article  PubMed  CAS  Google Scholar 

  19. Shi, H., Chai, P., Jia, R. & Fan, X. Novel insight into the regulatory roles of diverse RNA modifications: re-defining the bridge between transcription and translation. Mol. Cancer 19, 78 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Liu, C. et al. Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI. Nat. Biotechnol. 41, 355–366 (2023).

    Article  PubMed  CAS  Google Scholar 

  21. Karijolich, J., Yi, C. & Yu, Y. T. Transcriptome-wide dynamics of RNA pseudouridylation. Nat. Rev. Mol. Cell Biol. 16, 581–585 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Li, X., Xiong, X. & Yi, C. Epitranscriptome sequencing technologies: decoding RNA modifications. Nat. Methods 14, 23–31 (2016).

    Article  PubMed  Google Scholar 

  23. Karijolich, J. & Yu, Y. T. Converting nonsense codons into sense codons by targeted pseudouridylation. Nature 474, 395–398 (2011).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Song, J. et al. CRISPR-free, programmable RNA pseudouridylation to suppress premature termination codons. Mol. Cell 83, 139–155 e139 (2023).

    Article  PubMed  CAS  Google Scholar 

  25. Adachi, H. et al. Targeted pseudouridylation: an approach for suppressing nonsense mutations in disease genes. Mol. Cell 83, 637–651 e639 (2023).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Dai, Q. et al. Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution. Nat. Biotechnol. 41, 344–354 (2023).

    Article  PubMed  CAS  Google Scholar 

  27. Svidritskiy, E., Madireddy, R. & Korostelev, A. A. Structural basis for translation termination on a pseudouridylated stop codon. J. Mol. Biol. 428, 2228–2236 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Eyler, D. E. et al. Pseudouridinylation of mRNA coding sequences alters translation. Proc. Natl Acad. Sci. USA 116, 23068–23074 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Luo, N. et al. Near-cognate tRNAs increase the efficiency and precision of pseudouridine-mediated readthrough of premature termination codons. Nat. Biotechnol. 43, 114–123 (2024).

    Article  PubMed  Google Scholar 

  30. Liu, J. et al. RNA codon expansion via programmable pseudouridine editing and decoding. Nature https://doi.org/10.1038/s41586-025-09165-x (2025).

  31. Hoernes, T. P. et al. Nucleotide modifications within bacterial messenger RNAs regulate their translation and are able to rewire the genetic code. Nucleic Acids Res. 44, 852–862 (2016).

    Article  PubMed  CAS  Google Scholar 

  32. Kim, K. Q. et al. N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products. Cell Rep. 40, 111300 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Hoernes, T. P. et al. Eukaryotic translation elongation is modulated by single natural nucleotide derivatives in the coding sequences of mRNAs. Genes 10, 84 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Pederiva, C. et al. Control of protein synthesis through mRNA pseudouridylation by dyskerin. Sci. Adv. 9, eadg1805 (2023).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Monroe, J. et al. N1-Methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translation. Nat. Commun. 15, 8119 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Cui, Q. et al. Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis. Nat. Cancer 2, 932–949 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Vare, V. Y., Eruysal, E. R., Narendran, A., Sarachan, K. L. & Agris, P. F. Chemical and conformational diversity of modified nucleosides affects tRNA structure and function. Biomolecules 7, 29 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  38. Alexandrov, A. et al. Rapid tRNA decay can result from lack of nonessential modifications. Mol. Cell 21, 87–96 (2006).

    Article  PubMed  CAS  Google Scholar 

  39. Kimura, S. & Waldor, M. K. The RNA degradosome promotes tRNA quality control through clearance of hypomodified tRNA. Proc. Natl Acad. Sci. USA 116, 1394–1403 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Khonsari, B. & Klassen, R. Impact of Pus1 pseudouridine synthase on specific decoding events in Saccharomyces cerevisiae. Biomolecules 10, 729 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Schultz, S. K. et al. Modifications in the T arm of tRNA globally determine tRNA maturation, function, and cellular fitness. Proc. Natl Acad. Sci. USA 121, e2401154121 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Giege, R. & Eriani, G. The tRNA identity landscape for aminoacylation and beyond. Nucleic Acids Res. 51, 1528–1570 (2023).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Levi, O. & Arava, Y. S. Pseudouridine-mediated translation control of mRNA by methionine aminoacyl tRNA synthetase. Nucleic Acids Res. 49, 432–443 (2021).

    Article  PubMed  CAS  Google Scholar 

  44. Blanchet, S. et al. Deciphering the reading of the genetic code by near-cognate tRNA. Proc. Natl Acad. Sci. USA 115, 3018–3023 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Addepalli, B. & Limbach, P. A. Pseudouridine in the anticodon of Escherichia coli tRNATyr(QPsiA) is catalyzed by the dual specificity enzyme rluF. J. Biol. Chem. 291, 22327–22337 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  46. Tagel, M. et al. Pseudouridines of tRNA anticodon stem-loop have unexpected role in mutagenesis in Pseudomonas sp. Microorganisms 9, 25 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  47. Lecointe, F. et al. Lack of pseudouridine 38/39 in the anticodon arm of yeast cytoplasmic tRNA decreases in vivo recoding efficiency. J. Biol. Chem. 277, 30445–30453 (2002).

    Article  PubMed  CAS  Google Scholar 

  48. Urbonavicius, J., Qian, Q., Durand, J. M., Hagervall, T. G. & Bjork, G. R. Improvement of reading frame maintenance is a common function for several tRNA modifications. EMBO J. 20, 4863–4873 (2001).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Kumar, P., Kuscu, C. & Dutta, A. Biogenesis and function of transfer RNA-related fragments (tRFs). Trends Biochem. Sci. 41, 679–689 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  50. Guzzi, N. et al. Pseudouridylation of tRNA-derived fragments steers translational control in stem cells. Cell 173, 1204–1216 e1226 (2018).

    Article  PubMed  CAS  Google Scholar 

  51. Guzzi, N. et al. Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome. Nat. Cell Biol. 24, 299–306 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  52. Taoka, M. et al. Landscape of the complete RNA chemical modifications in the human 80S ribosome. Nucleic Acids Res. 46, 9289–9298 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Holvec, S. et al. The structure of the human 80S ribosome at 1.9 Å resolution reveals the molecular role of chemical modifications and ions in RNA. Nat. Struct. Mol. Biol. 31, 1251–1264 (2024).

    Article  PubMed  CAS  Google Scholar 

  54. Leppik, M. et al. Loss of conserved rRNA modifications in the peptidyl transferase center leads to diminished protein synthesis and cell growth in budding yeast. Int. J. Mol. Sci. 25, 5194 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Liang, X. H., Liu, Q. & Fournier, M. J. Loss of rRNA modifications in the decoding center of the ribosome impairs translation and strongly delays pre-rRNA processing. RNA 15, 1716–1728 (2009).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  56. Baudin-Baillieu, A. et al. Nucleotide modifications in three functionally important regions of the Saccharomyces cerevisiae ribosome affect translation accuracy. Nucleic Acids Res. 37, 7665–7677 (2009).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  57. McMahon, M. et al. A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS. eLife 8, e48847 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  58. Ero, R., Leppik, M., Reier, K., Liiv, A. & Remme, J. Ribosomal RNA modification enzymes stimulate large ribosome subunit assembly in E. coli. Nucleic Acids Res. 52, 6614–6628 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  59. Zhao, Y., Rai, J., Yu, H. & Li, H. CryoEM structures of pseudouridine-free ribosome suggest impacts of chemical modifications on ribosome conformations. Structure 30, 983–992 e985 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Liang, X. H., Liu, Q. & Fournier, M. J. rRNA modifications in an intersubunit bridge of the ribosome strongly affect both ribosome biogenesis and activity. Mol. Cell 28, 965–977 (2007).

    Article  PubMed  CAS  Google Scholar 

  61. Jiang, J., Aduri, R., Chow, C. S. & SantaLucia, J. Jr Structure modulation of helix 69 from Escherichia coli 23S ribosomal RNA by pseudouridylations. Nucleic Acids Res. 42, 3971–3981 (2014).

    Article  PubMed  CAS  Google Scholar 

  62. Rajan, K. S. et al. Structural and mechanistic insights into the function of Leishmania ribosome lacking a single pseudouridine modification. Cell Rep. 43, 114203 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Rajan, K. S. et al. A single pseudouridine on rRNA regulates ribosome structure and function in the mammalian parasite Trypanosoma brucei. Nat. Commun. 14, 7462 (2023).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Jack, K. et al. rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol. Cell 44, 660–666 (2011).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  65. Ruggero, D. et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299, 259–262 (2003).

    Article  PubMed  CAS  Google Scholar 

  66. Ding, H. et al. Implications of RNA pseudouridylation for cancer biology and therapeutics: a narrative review. J. Transl. Med. 22, 906 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Zhao, Y., Rai, J. & Li, H. Regulation of translation by ribosomal RNA pseudouridylation. Sci. Adv. 9, eadg8190 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  68. Leppik, M., Liiv, A. & Remme, J. Random pseuoduridylation in vivo reveals critical region of Escherichia coli 23S rRNA for ribosome assembly. Nucleic Acids Res. 45, 6098–6108 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  69. Spitale, R. C. & Incarnato, D. Probing the dynamic RNA structurome and its functions. Nat. Rev. Genet. 24, 178–196 (2023).

    Article  PubMed  CAS  Google Scholar 

  70. Cao, X. A., Zhang, Y. Y., Ding, Y. L. & Wan, Y. Identification of RNA structures and their roles in RNA functions. Nat. Rev. Mol. Cell Biol. 25, 784–801 (2024).

    Article  PubMed  CAS  Google Scholar 

  71. Strobel, E. J., Yu, A. M. & Lucks, J. B. High-throughput determination of RNA structures. Nat. Rev. Genet. 19, 615–634 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  72. Sun, L. et al. RNA structure maps across mammalian cellular compartments. Nat. Struct. Mol. Biol. 26, 322-–330 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  73. Rubtsov, P. M. Role of pre-mRNA secondary structures in the regulation of alternative splicing. Mol. Biol. 50, 823–830 (2016).

    Article  CAS  Google Scholar 

  74. McManus, C. J. & Graveley, B. R. RNA structure and the mechanisms of alternative splicing. Curr. Opin. Genet. Dev. 21, 373–379 (2011).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Rodell, R., Robalin, N. & Martinez, N. M. Why U matters: detection and functions of pseudouridine modifications in mRNAs. Trends Biochem. Sci. 49, 12–27 (2024).

    Article  PubMed  CAS  Google Scholar 

  76. Hudson, G. A., Bloomingdale, R. J. & Znosko, B. M. Thermodynamic contribution and nearest-neighbor parameters of pseudouridine-adenosine base pairs in oligoribonucleotides. RNA 19, 1474–1482 (2013).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Vögele, J. et al. Structural and dynamic effects of pseudouridine modifications on noncanonical interactions in RNA. RNA 29, 790–807 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  78. Deb, I. et al. Computational and NMR studies of RNA duplexes with an internal pseudouridine-adenosine base pair. Sci. Rep. 9, 16278 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  79. Davis, D. R. Stabilization of RNA stacking by pseudouridine. Nucleic Acids Res. 23, 5020–5026 (1995).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  80. Meroueh, M. et al. Unique structural and stabilizing roles for the individual pseudouridine residues in the 1920 region of Escherichia coli 23S rRNA. Nucleic Acids Res. 28, 2075–2083 (2000).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  81. Wu, G. W., Xiao, M., Yang, C. X. & Yu, Y. T. U2 snRNA is inducibly pseudouridylated at novel sites by Pus7p and snR81 RNP. EMBO J. 30, 79–89 (2011).

    Article  PubMed  Google Scholar 

  82. Rajan, K. S. et al. Pseudouridines on Trypanosoma brucei spliceosomal small nuclear RNAs and their implication for RNA and protein interactions. Nucleic Acids Res. 47, 7633–7647 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  83. Chen, J. L., Leeder, W. M., Morais, P., Adachi, H. & Yu, Y. T. Pseudouridylation-mediated gene expression modulation. Biochem. J. 481, 1–16 (2024).

    Article  PubMed  CAS  Google Scholar 

  84. Kennedy, S. D., Bauer, W. J., Wang, W. H. & Kielkopf, C. L. Dynamic stacking of an expected branch point adenosine in duplexes containing pseudouridine-modified or unmodified U2 snRNA sites. Biochem. Bioph Res. Co. 511, 416–421 (2019).

    Article  CAS  Google Scholar 

  85. Wu, G. et al. Pseudouridines in U2 snRNA stimulate the ATPase activity of Prp5 during spliceosome assembly. EMBO J. 35, 654–667 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  86. Martinez, N. M. et al. Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing. Mol. Cell 82, 645–659 e649 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  87. Chen, C., Zhao, X., Kierzek, R. & Yu, Y. T. A flexible RNA backbone within the polypyrimidine tract is required for U2AF65 binding and pre-mRNA splicing in vivo. Mol. Cell Biol. 30, 4108–4119 (2010).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  88. Leppek, K. et al. Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics. Nat. Commun. 13, 1536 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  89. Mauger, D. M. et al. mRNA structure regulates protein expression through changes in functional half-life. Proc. Natl Acad. Sci. USA 116, 24075–24083 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  90. Anderson, B. R. et al. Nucleoside modifications in RNA limit activation of 2′-5′-oligoadenylate synthetase and increase resistance to cleavage by RNase L. Nucleic Acids Res. 39, 9329–9338 (2011).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  91. Islam, M. S., Bandyra, K. J., Chao, Y. J., Vogel, J. & Luisi, B. Impact of pseudouridylation, substrate fold, and degradosome organization on the endonuclease activity of RNase E. RNA 27, 1339–1352 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  92. Sun, H., Li, K., Liu, C. & Yi, C. Regulation and functions of non-m6A mRNA modifications. Nat. Rev. Mol. Cell Biol. 24, 714–731 (2023).

    Article  PubMed  CAS  Google Scholar 

  93. Zhang, M. et al. Quantitative profiling of pseudouridylation landscape in the human transcriptome. Nat. Chem. Biol. 19, 1185–1195 (2023).

    Article  PubMed  CAS  Google Scholar 

  94. Suzuki, T. et al. Complete chemical structures of human mitochondrial tRNAs. Nat. Commun. 11, 4269 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  95. Antonicka, H. et al. A pseudouridine synthase module is essential for mitochondrial protein synthesis and cell viability. EMBO Rep. 18, 28–38 (2017).

    Article  PubMed  CAS  Google Scholar 

  96. Zaganelli, S. et al. The pseudouridine synthase RPUSD4 is an essential component of mitochondrial RNA granules. J. Biol. Chem. 292, 4519–4532 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  97. Borchardt, E. K., Martinez, N. M. & Gilbert, W. V. Regulation and function of RNA pseudouridylation in human cells. Annu. Rev. Genet. 54, 309–336 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  98. Roovers, M., Droogmans, L. & Grosjean, H. Post-transcriptional modifications of conserved nucleotides in the T-loop of tRNA: a tale of functional convergent evolution. Genes 12, 140 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  99. Mukhopadhyay, S., Deogharia, M. & Gupta, R. Mammalian nuclear TRUB1, mitochondrial TRUB2, and cytoplasmic PUS10 produce conserved pseudouridine 55 in different sets of tRNA. RNA 27, 66–79 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  100. Jia, Z. et al. Human TRUB1 is a highly conserved pseudouridine synthase responsible for the formation of Psi55 in mitochondrial tRNAAsn, tRNAGln, tRNAGlu and tRNAPro. Nucleic Acids Res. 50, 9368–9381 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  101. Wang, B. et al. Mitochondrial tRNA pseudouridylation governs erythropoiesis. Blood 144, 657–671 (2024).

    Article  PubMed  CAS  Google Scholar 

  102. Safra, M., Nir, R., Farouq, D., Vainberg Slutskin, I. & Schwartz, S. TRUB1 is the predominant pseudouridine synthase acting on mammalian mRNA via a predictable and conserved code. Genome Res. 27, 393–406 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  103. Kramer, N. J. et al. Regulators of mitonuclear balance link mitochondrial metabolism to mtDNA expression. Nat. Cell Biol. 25, 1575–1589 (2023).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  104. Perks, K. L. et al. PTCD1 is required for 16S rRNA maturation complex stability and mitochondrial ribosome assembly. Cell Rep. 23, 127–142 (2018).

    Article  PubMed  CAS  Google Scholar 

  105. Chu, Y. J. et al. Mitochondrial tRNA pseudouridylation regulates erythropoiesis via the mTOR signaling pathway: implications for mlasa and treatment strategies. Blood 142 (Suppl. 1), 139 (2023).

    Article  Google Scholar 

  106. Ding, Y., Gao, B. & Huang, J. Mitochondrial cardiomyopathy: the roles of mt-tRNA Mutations. J. Clin. Med. 11, 6431 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  107. Shi, D. et al. Pseudouridine synthase 1 regulates erythropoiesis via transfer RNAs pseudouridylation and cytoplasmic translation. iScience 27, 109265 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  108. Song, J., Zhuang, Y. & Yi, C. Programmable RNA base editing via targeted modifications. Nat. Chem. Biol. 20, 277–290 (2024).

    Article  PubMed  CAS  Google Scholar 

  109. Song, J., Luo, N., Dong, L., Peng, J. & Yi, C. RNA base editors: the emerging approach of RNA therapeutics. Wiley Interdiscip. Rev. RNA 15, e1844 (2024).

    Article  PubMed  CAS  Google Scholar 

  110. Springer, A. D. & Dowdy, S. F. GalNAc–siRNA conjugates: leading the way for delivery of RNAi therapeutics. Nucleic Acid. Ther. 28, 109–118 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  111. Cui, H., Zhu, X., Li, S., Wang, P. & Fang, J. Liver-targeted delivery of oligonucleotides with N-acetylgalactosamine conjugation. ACS Omega 6, 16259–16265 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  112. White, M. B. et al. A frame-shift mutation in the cystic fibrosis gene. Nature 344, 665–667 (1990).

    Article  PubMed  CAS  Google Scholar 

  113. Monaco, A. P., Bertelson, C. J., Liechti-Gallati, S., Moser, H. & Kunkel, L. M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2, 90–95 (1988).

    Article  PubMed  CAS  Google Scholar 

  114. Lau, M. M. & Neufeld, E. F. A frameshift mutation in a patient with Tay–Sachs disease causes premature termination and defective intracellular transport of the alpha-subunit of β-hexosaminidase. J. Biol. Chem. 264, 21376–21380 (1989).

    Article  PubMed  CAS  Google Scholar 

  115. Nir, R. et al. A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA. Nucleic Acids Res. 50, 4900–4916 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  116. Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines — a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261–279 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  117. Kariko, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175 (2005).

    Article  PubMed  CAS  Google Scholar 

  118. Durbin, A. F., Wang, C., Marcotrigiano, J. & Gehrke, L. RNAs containing modified nucleotides fail to trigger RIG-I conformational changes for innate immune signaling. mBio 7, e00833-16 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  119. Anderson, B. R. et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Res. 38, 5884–5892 (2010).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  120. Andries, O. et al. N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J. Control. Rel. 217, 337–344 (2015).

    Article  CAS  Google Scholar 

  121. Nelson, J. et al. Impact of mRNA chemistry and manufacturing process on innate immune activation. Sci. Adv. 6, eaaz6893 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  122. Pardi, N. et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 543, 248–251 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  123. Richner, J. M. et al. Modified mRNA vaccines protect against zika virus infection. Cell 169, 176 (2017).

    Article  PubMed  CAS  Google Scholar 

  124. Pardi, N. et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J. Exp. Med. 215, 1571–1588 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  125. Morais, P., Adachi, H. & Yu, Y. T. The critical contribution of pseudouridine to mRNA COVID-19 vaccines. Front. Cell Dev. Biol. 9, 789427 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  126. Granados-Riveron, J. T. & Aquino-Jarquin, G. Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2. Biomed. Pharmacother. 142, 111953 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  127. Mulroney, T. E. et al. N1-methylpseudouridylation of mRNA causes +1 ribosomal frameshifting. Nature 625, 189–194 (2024).

    Article  PubMed  CAS  Google Scholar 

  128. Wang, Y., Zhang, L., Xu, Z., Miao, L. & Huang, L. mRNA vaccine with antigen-specific checkpoint blockade induces an enhanced immune response against established melanoma. Mol. Ther. 26, 420–434 (2018).

    Article  PubMed  Google Scholar 

  129. Sittplangkoon, C. et al. mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model. Front. Immunol. 13, 983000 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  130. Rubio-Casillas, A., Cowley, D., Raszek, M., Uversky, V. N. & Redwan, E. M. Review: N1-methyl-pseudouridine (m1Psi): friend or foe of cancer? Int. J. Biol. Macromol. 267, 131427 (2024).

    Article  PubMed  CAS  Google Scholar 

  131. Ramos da Silva, J. et al. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice. Sci. Transl. Med. 15, eabn3464 (2023).

    Article  PubMed  CAS  Google Scholar 

  132. Broos, K. et al. Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T-cell responses despite the induction of type I interferon. Mol. Ther. Nucleic Acids 5, e326 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  133. Rojas, L. A. et al. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature 618, 144–150 (2023).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  134. Lovejoy, A. F., Riordan, D. P. & Brown, P. O. Transcriptome-wide mapping of pseudouridines: pseudouridine synthases modify specific mRNAs in S. cerevisiae. PLoS ONE 9, e110799 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  135. Kurimoto, R. et al. The tRNA pseudouridine synthase TruB1 regulates the maturation of let-7 miRNA. EMBO J. 39, e104708 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  136. Song, J. et al. Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation. Nat. Chem. Biol. 16, 160–169 (2020).

    Article  PubMed  CAS  Google Scholar 

  137. Zaringhalam, M. & Papavasiliou, F. N. Pseudouridylation meets next-generation sequencing. Methods 107, 63–72 (2016).

    Article  PubMed  CAS  Google Scholar 

  138. Zhao, L. Y., Song, J., Liu, Y., Song, C. X. & Yi, C. Mapping the epigenetic modifications of DNA and RNA. Protein Cell 11, 792–808 (2020).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  139. Khoddami, V. et al. Transcriptome-wide profiling of multiple RNA modifications simultaneously at single-base resolution. Proc. Natl Acad. Sci. USA 116, 6784–6789 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  140. Fleming, A. M. et al. Structural elucidation of bisulfite adducts to pseudouridine that result in deletion signatures during reverse transcription of RNA. J. Am. Chem. Soc. 141, 16450–16460 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  141. Zhang, M., Xiao, Y., Jiang, Z. & Yi, C. Quantifying m6A and Ψ modifications in the transcriptome via chemical-assisted approaches. Acc. Chem. Res. 56, 2980–2991 (2023).

    Article  PubMed  CAS  Google Scholar 

  142. Xu, H. et al. Absolute quantitative and base-resolution sequencing reveals comprehensive landscape of pseudouridine across the human transcriptome. Nat. Methods 21, 2024–2033 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  143. Huang, S. et al. Interferon inducible pseudouridine modification in human mRNA by quantitative nanopore profiling. Genome Biol. 22, 330 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  144. Tavakoli, S. et al. Semi-quantitative detection of pseudouridine modifications and type I/II hypermodifications in human mRNAs using direct long-read sequencing. Nat. Commun. 14, 334 (2023).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  145. Begik, O. et al. Quantitative profiling of pseudouridylation dynamics in native RNAs with nanopore sequencing. Nat. Biotechnol. 39, 1278–1291 (2021).

    Article  PubMed  CAS  Google Scholar 

  146. Makhamreh, A. et al. Nanopore signal deviations from pseudouridine modifications in RNA are sequence-specific: quantification requires dedicated synthetic controls. Sci. Rep. 14, 22457 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  147. Huang, S., Wylder, A. C. & Pan, T. Simultaneous nanopore profiling of mRNA m6A and pseudouridine reveals translation coordination. Nat. Biotechnol. 42, 1831–1835 (2024).

    Article  PubMed  CAS  Google Scholar 

  148. Lucas, M. C. et al. Quantitative analysis of tRNA abundance and modifications by nanopore RNA sequencing. Nat. Biotechnol. 42, 72–86 (2024).

    Article  PubMed  CAS  Google Scholar 

  149. Zhang, M., Zhang, X., Ma, Y. & Yi, C. New directions for Psi and m1A decoding in mRNA: deciphering the stoichiometry and function. RNA 30, 537–547 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  150. Gilbert, W. V. Recent developments, opportunities, and challenges in the study of mRNA pseudouridylation. RNA 30, 530–536 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  151. Liu, N. et al. Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA. RNA 19, 1848–1856 (2013).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  152. Lei, Z. & Yi, C. A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection. Angew. Chem. Int. Ed. Engl. 56, 14878–14882 (2017).

    Article  PubMed  CAS  Google Scholar 

  153. Zhang, W., Eckwahl, M. J., Zhou, K. I. & Pan, T. Sensitive and quantitative probing of pseudouridine modification in mRNA and long noncoding RNA. RNA 25, 1218–1225 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  154. Zhao, Y. et al. Pseudouridine detection and quantification using bisulfite incorporation hindered ligation. ACS Chem. Biol. 19, 1813–1819 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  155. Fang, X. et al. A bisulfite-assisted and ligation-based qPCR amplification technology for locus-specific pseudouridine detection at base resolution. Nucleic Acids Res. 52, e49 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  156. Keffer-Wilkes, L. C., Veerareddygari, G. R. & Kothe, U. RNA modification enzyme TruB is a tRNA chaperone. Proc. Natl Acad. Sci. USA 113, 14306–14311 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  157. Liu, X. M., Zhou, J., Mao, Y., Ji, Q. & Qian, S. B. Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates. Nat. Chem. Biol. 15, 865–871 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  158. Xu, C. et al. Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain. Nat. Chem. Biol. 10, 927–929 (2014).

    Article  PubMed  CAS  Google Scholar 

  159. Li, F., Zhao, D., Wu, J. & Shi, Y. Structure of the YTH domain of human YTHDF2 in complex with an m6A mononucleotide reveals an aromatic cage for m6A recognition. Cell Res. 24, 1490–1492 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  160. Theler, D., Dominguez, C., Blatter, M., Boudet, J. & Allain, F. H. Solution structure of the YTH domain in complex with N6-methyladenosine RNA: a reader of methylated RNA. Nucleic Acids Res. 42, 13911–13919 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  161. Vaidyanathan, P. P., AlSadhan, I., Merriman, D. K., Al-Hashimi, H. M. & Herschlag, D. Pseudouridine and N6-methyladenosine modifications weaken PUF protein/RNA interactions. RNA 23, 611–618 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  162. deLorimier, E. et al. Pseudouridine modification inhibits muscleblind-like 1 (MBNL1) binding to CCUG repeats and minimally structured RNA through reduced RNA flexibility. J. Biol. Chem. 292, 4350–4357 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  163. Edupuganti, R. R. et al. N6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis. Nat. Struct. Mol. Biol. 24, 870–878 (2017).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  164. Fu, Y., Dominissini, D., Rechavi, G. & He, C. Gene expression regulation mediated through reversible m6A RNA methylation. Nat. Rev. Genet. 15, 293–306 (2014).

    Article  PubMed  CAS  Google Scholar 

  165. Stockert, J. A., Weil, R., Yadav, K. K., Kyprianou, N. & Tewari, A. K. Pseudouridine as a novel biomarker in prostate cancer. Urol. Oncol. 39, 63–71 (2021).

    Article  PubMed  CAS  Google Scholar 

  166. Cerneckis, J., Cui, Q., He, C., Yi, C. & Shi, Y. Decoding pseudouridine: an emerging target for therapeutic development. Trends Pharmacol. Sci. 43, 522–535 (2022).

    Article  PubMed  CAS  Google Scholar 

  167. Seidel, A., Brunner, S., Seidel, P., Fritz, G. I. & Herbarth, O. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. Br. J. Cancer 94, 1726–1733 (2006).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  168. Mengel-Jorgensen, J. & Kirpekar, F. Detection of pseudouridine and other modifications in tRNA by cyanoethylation and MALDI mass spectrometry. Nucleic Acids Res. 30, e135 (2002).

    Article  PubMed  PubMed Central  Google Scholar 

  169. Popova, A. M. & Williamson, J. R. Quantitative analysis of rRNA modifications using stable isotope labeling and mass spectrometry. J. Am. Chem. Soc. 136, 2058–2069 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  170. Yamauchi, Y. et al. A mass spectrometry-based method for direct determination of pseudouridine in RNA. Nucleic Acids Res. 44, e59 (2016).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (22425071 and 22337001 to C.Y., and 32200467 to Q.H.), the National Key R&D Program of China (2023YFC3402200 to C.Y. and 2021YFC2302400 to M.Z.), Beijing Municipal Science & Technology Commission (Z231100002723005 to C.Y.) and the Ministry of Agriculture and Rural Affairs of China (NK2022010102 to C.Y.). Q.H. was supported in part by the Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences.

Author information

Authors and Affiliations

Authors

Contributions

The authors contributed equally to all aspects of the article.

Corresponding author

Correspondence to Chengqi Yi.

Ethics declarations

Competing interests

The authors have filed several patents for the RESTART technology.

Peer review

Peer review information

Nature Reviews Molecular Cell Biology thanks Ute Kothe, who reviewed with Sarah Schultz, Lorenzo Montanaro, who reviewed with Giulia Venturi, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Glossary

Ψ-based RNA editors

A type of RNA single-base editor that introduce pseudouridine (Ψ) modifications at specific sites, thereby altering the function of RNA molecules.

Box H/ACA small nucleolar ribonucleoproteins

A complex responsible for RNA-dependent pseudouridylation, consisting of a H/ACA box small nucleolar RNA and four proteins: NHP2, NOP10, GAR1 and DKC1.

Box H/ACA small nucleolar RNA

Small nucleolar RNA that contain conserved H/ACA boxes for the recognition of partner proteins, and a pseudouridylation pocket, which directs base pairing with the substrate RNA.

Folding traps

A type of RNA folding problem of misfolding into inactive, often long-lived conformations, making the escape from these conformations a rate-limiting step in the folding process.

Near-cognate tRNAs

Endogenous tRNAs whose anticodon forms partial base pairing with a specific codon on the mRNA, allowing the incorporation of non-canonical amino acids during translation.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, N., Huang, Q., Zhang, M. et al. Functions and therapeutic applications of pseudouridylation. Nat Rev Mol Cell Biol 26, 691–705 (2025). https://doi.org/10.1038/s41580-025-00852-1

Download citation

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41580-025-00852-1

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing